Pregnancy Complications
Welcome,         Profile    Billing    Logout  
 52 Companies   89 Products   89 Products   71 Mechanisms of Action   3 Trials   1543 News 


12345678910111213...3031»
  • ||||||||||  metformin / Generic mfg.
    Trial completion date:  Metformin Compared to Glyburide in Gestational Diabetes (clinicaltrials.gov) -  Dec 20, 2023   
    P=N/A,  N=149, Completed, 
    N=100 --> 168 Trial completion date: May 2008 --> Aug 2023
  • ||||||||||  Trial termination:  BIODOP-T1: Early Placental Insufficiency Screening (clinicaltrials.gov) -  May 16, 2023   
    P=N/A,  N=226, Terminated, 
    Trial completion date: May 2008 --> Aug 2023 Completed --> Terminated; Shortness inclusions of patients
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Tot ou tard: Postpartum Screening of Type 2 Diabetes (clinicaltrials.gov) -  May 1, 2019   
    P=N/A,  N=121, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Biomarker, Trial completion, Trial completion date:  GDMPredict: Predictability of Gestational Diabetes Mellitus in First and Second Trimester (clinicaltrials.gov) -  Apr 26, 2019   
    P=N/A,  N=820, Completed, 
    Suspended --> Terminated; Halted prematurely due to low recruitment rate. Recruiting --> Completed | Trial completion date: Jun 2019 --> Dec 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Development of Pharmacokinetics Model in Pregnancy Women and Fetus (clinicaltrials.gov) -  Apr 25, 2019   
    P=N/A,  N=96, Completed, 
    Recruiting --> Completed | Trial completion date: Jun 2019 --> Dec 2018 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  The Impact of Bryophyllum on Preterm Delivery (clinicaltrials.gov) -  Apr 20, 2019   
    P4,  N=26, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=180 --> 26
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date, Trial primary completion date:  RECeiVe: Rebozo and External Cephalic Version in Breech Presentation. (clinicaltrials.gov) -  Feb 22, 2019   
    P=N/A,  N=370, Completed, 
    Terminated --> Withdrawn Recruiting --> Completed | Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018
  • ||||||||||  irbesartan / Generic mfg.
    Trial completion date, Trial suspension, Trial primary completion date:  Preeclampsia: A Marker for Future Cardiovascular Risk in Women (clinicaltrials.gov) -  Jan 17, 2019   
    P=N/A,  N=150, Suspended, 
    Enrolling by invitation --> Completed Trial completion date: Jun 2018 --> Jul 2019 | Recruiting --> Suspended | Trial primary completion date: Jun 2018 --> Jul 2017
  • ||||||||||  Trial completion, Trial completion date:  Free DNA and Nucleosome Concentrations in Pathological Pregnancies (clinicaltrials.gov) -  Jan 11, 2019   
    P=N/A,  N=137, Completed, 
    Active, not recruiting --> Terminated; lack of funding Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Dec 2018
  • ||||||||||  Betaseron (IFN-?-1b) / Bayer
    Phase classification:  Betaseron Pregnancy Registry (clinicaltrials.gov) -  Dec 12, 2018   
    P=N/A,  N=113, Completed, 
    Active, not recruiting --> Completed Phase classification: P4 --> P=N/A
  • ||||||||||  metformin / Generic mfg.
    Trial completion, Enrollment change:  Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes (clinicaltrials.gov) -  Nov 28, 2018   
    P=N/A,  N=25, Completed, 
    Phase classification: P4 --> P=N/A Recruiting --> Completed | N=100 --> 25
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes (clinicaltrials.gov) -  Nov 28, 2018   
    P=N/A,  N=643, Completed, 
    Recruiting --> Completed | N=100 --> 25 Trial completion date: Nov 2017 --> Jul 2017 | Trial primary completion date: Nov 2017 --> Jul 2017
  • ||||||||||  Trial completion date, Trial primary completion date:  Free DNA and Nucleosome Concentrations in Pathological Pregnancies (clinicaltrials.gov) -  Nov 26, 2018   
    P=N/A,  N=180, Active, not recruiting, 
    Trial completion date: Nov 2017 --> Jul 2017 | Trial primary completion date: Nov 2017 --> Jul 2017 Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Jul 2018 --> Dec 2018
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Enrollment closed, Trial completion date, Trial primary completion date:  Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial (clinicaltrials.gov) -  Nov 21, 2018   
    P4,  N=416, Active, not recruiting, 
    Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Jul 2018 --> Dec 2018 Recruiting --> Active, not recruiting | Trial completion date: Jan 2017 --> Dec 2018 | Trial primary completion date: Jan 2017 --> Dec 2018
  • ||||||||||  carbetocin / Generic mfg.
    Trial completion:  IMox: Intramuscular Oxytocics: A Randomised Control Trial (clinicaltrials.gov) -  Nov 14, 2018   
    P3,  N=5798, Completed, 
    Recruiting --> Active, not recruiting | Trial completion date: Jan 2017 --> Dec 2018 | Trial primary completion date: Jan 2017 --> Dec 2018 Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date:  Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy (clinicaltrials.gov) -  Nov 8, 2018   
    P4,  N=894, Completed, 
    Active, not recruiting --> Terminated; Expired with the IRB Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2017
  • ||||||||||  Trial completion:  Evaluating Patient Information Prescriptions (clinicaltrials.gov) -  Oct 23, 2018   
    P2,  N=299, Completed, 
    Phase classification: P2/3 --> P2 Active, not recruiting --> Completed
  • ||||||||||  acetylcysteine solution / Generic mfg.
    Trial completion date, Adverse events:  N-acetylcysteine in Intra-amniotic Infection/Inflammation (clinicaltrials.gov) -  Oct 10, 2018   
    P1/2,  N=68, Completed, 
    Recruiting --> Completed | Trial completion date: Oct 2017 --> Mar 2017 | Trial primary completion date: Aug 2017 --> Dec 2016 Trial completion date: Nov 2016 --> Aug 2018
  • ||||||||||  Balfaxar (prothrombin complex concentrate, human-lans) / Octapharma, Pfizer, NN1213 / Novo Nordisk
    Enrollment change, Trial completion date, Trial primary completion date:  PCC and Fibrinogen Compared With FFP in PPH (clinicaltrials.gov) -  Oct 10, 2018   
    P4,  N=0, Withdrawn, 
    Trial completion date: Nov 2016 --> Aug 2018 N=40 --> 0 | Trial completion date: Dec 2014 --> Oct 2018 | Trial primary completion date: Sep 2014 --> Oct 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Treating Prediabetes in the First Trimester (clinicaltrials.gov) -  Oct 10, 2018   
    P=N/A,  N=202, Completed, 
    N=40 --> 0 | Trial completion date: Dec 2014 --> Oct 2018 | Trial primary completion date: Sep 2014 --> Oct 2018 Terminated --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial termination, Trial primary completion date:  Vaginal Pessary Versus Expectant Management for Placenta Previa (clinicaltrials.gov) -  Sep 27, 2018   
    P=N/A,  N=17, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Sep 2018 Trial completion date: Dec 2022 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2022 --> Sep 2018; Study was terminated early do to a business decision by sponsor and lack of ability to recruit the needed number of participants.
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Delayed Clamping and Milking the Umbilical Cord in Preterm Infants (clinicaltrials.gov) -  Sep 11, 2018   
    P=N/A,  N=282, Completed, 
    Trial completion date: Dec 2022 --> Sep 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2022 --> Sep 2018; Study was terminated early do to a business decision by sponsor and lack of ability to recruit the needed number of participants. Recruiting --> Completed